Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Pulmonary/Respiratory Diseases
Idiopathic Pulmonary Fibrosis Clinical Trials
A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 Last
Alabama
University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care
Updated
A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis
University of Alabama at Birmingham
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
The Kirklin Clinic
Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis
1199.33.01012 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Arizona
Arizona Pulmonary Specialists
A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
1199.33.01003 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Arizona Pulmonary Specialists, Ltd.
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Saint Joseph's Hospital and Medical Center
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Research Site
A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis
View More »
Arizona Pulmonary Specialists, Ltd.
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Mayo Clinic Arizona
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Research Site
A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis
University of Arizona
A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
The University of Arizona
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
California
View More »
Research Site
A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis
VA Greater LA Health Care System-UCLA
A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
1199.33.01029 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical Center
Updated
A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis
David Geffen School of Medicine at University of California, Los Angeles
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
David Geffen School of Medicine UCLA
A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension
David Geffen School of Medicine, UCLA
Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis
David Geffen School of Medicine UCLA
Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
Departments of Pulmonary and Critical Care, Cardiothoracic Surgery and Infectious Diseases at David Geffen School of Medicine at UCLA
Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
University of California- Davis Medical Center
A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
University of California Davis Medical Center
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Research Site
A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis
1199.33.01030 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
1199.33.01026 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Sansum Clinic
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
1199.33.01035 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Stanford University Medical Center
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
1199.33.01007 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Colorado
National Jewish Health
A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis
National Jewish Health
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Wheat Ridge Colorado 80033Updated
A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis
Connecticut
1199.33.01006 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Yale University School of Medicine
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Yale University
Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis
1199.33.01017 Boehringer Ingelheim Investigational Site
Updated
A clinical research study of BIBF 1120 for the treatment of Idiopathic Pulmonary Fibrosis
Florida
University of Miami
STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
View More »
Bay Area Chest Physicians
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
University of Florida
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
University of Miami
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Research Site
A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis
Orlando Florida 32803Updated
A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis
Sarasota Memorial Hospital
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
Tampa General Hospital
Updated
A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis
First 1 2 3 4 5 6 Last
